NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today reported 14 percent growth in revenues year over year for the first quarter as the Analytical Technologies and Specialty Diagnostics segments each grew more than 20 percent.

For the period ended March 31, total revenues rose to $3.10 billion from $2.72 billion, besting Wall Street estimates of $2.98 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.